OBJECTIVE: Recently, vitamin D deficiency has been associated with increased risks for preeclampsia and diagnosis of early-onset, severe preeclampsia (EOSPE). The purpose of this investigation was to examine the association between vitamin D levels and small-for-gestational age (SGA) in patients with EOSPE. STUDY DESIGN: Patients with EOSPE were recruited, and demographics, outcomes, and plasma were collected. We assessed 25-hydroxyvitamin D (25[OH]D) by radioimmunoassay and reported our findings in nanograms per milliliter. Results were analyzed by Mann-Whitney U test and Spearman correlation and were reported as median (Q1-Q3). RESULTS: In patients with EOSPE (n = 56), 25(OH)D was lower in patients with SGA (16.8 ng/mL; range, 8.9-23 ng/mL) vs normal fetal growth (25.3 ng/mL; range, 16-33 ng/mL; P = .02). 25(OH)D was correlated significantly with percentile growth at delivery (ρ = 0.31; P = .02). CONCLUSION: Vitamin D is lower among patients with SGA in EOSPE than those without growth retardation. We suspect that vitamin D may impact fetal growth through placental mechanisms.
OBJECTIVE: Recently, vitamin D deficiency has been associated with increased risks for preeclampsia and diagnosis of early-onset, severe preeclampsia (EOSPE). The purpose of this investigation was to examine the association between vitamin D levels and small-for-gestational age (SGA) in patients with EOSPE. STUDY DESIGN:Patients with EOSPE were recruited, and demographics, outcomes, and plasma were collected. We assessed 25-hydroxyvitamin D (25[OH]D) by radioimmunoassay and reported our findings in nanograms per milliliter. Results were analyzed by Mann-Whitney U test and Spearman correlation and were reported as median (Q1-Q3). RESULTS: In patients with EOSPE (n = 56), 25(OH)D was lower in patients with SGA (16.8 ng/mL; range, 8.9-23 ng/mL) vs normal fetal growth (25.3 ng/mL; range, 16-33 ng/mL; P = .02). 25(OH)D was correlated significantly with percentile growth at delivery (ρ = 0.31; P = .02). CONCLUSION:Vitamin D is lower among patients with SGA in EOSPE than those without growth retardation. We suspect that vitamin D may impact fetal growth through placental mechanisms.
Authors: Donna D Johnson; Carol L Wagner; Thomas C Hulsey; Rebecca B McNeil; Myla Ebeling; Bruce W Hollis Journal: Am J Perinatol Date: 2010-07-16 Impact factor: 1.862
Authors: D Fischer; A Schroer; D Lüdders; T Cordes; B Bücker; J Reichrath; M Friedrich Journal: Clin Exp Obstet Gynecol Date: 2007 Impact factor: 0.146
Authors: Carol L Wagner; Bruce W Hollis; Kalliopi Kotsa; Hana Fakhoury; Spyridon N Karras Journal: Rev Endocr Metab Disord Date: 2017-09 Impact factor: 6.514
Authors: Elena R Rivers; Anthony J Horton; Angela F Hawk; Elizabeth G Favre; Katherine M Senf; Paul J Nietert; Eugene Y Chang; Ann C Foley; Christopher J Robinson; Kyu-Ho Lee Journal: Hypertens Pregnancy Date: 2014-07-02 Impact factor: 2.108
Authors: J A Tamblyn; L E Jeffery; R Susarla; D M Lissauer; S L Coort; A Muñoz Garcia; K Knoblich; A L Fletcher; J N Bulmer; M D Kilby; M Hewison Journal: Reproduction Date: 2019-08 Impact factor: 3.906
Authors: Yan Tian; Claudia Holzman; Anna M Siega-Riz; Michelle A Williams; Nancy Dole; Daniel A Enquobahrie; Cynthia D Ferre Journal: Paediatr Perinat Epidemiol Date: 2015-11-17 Impact factor: 3.980
Authors: Carol L Wagner; Rebecca B McNeil; Donna D Johnson; Thomas C Hulsey; Myla Ebeling; Christopher Robinson; Stuart A Hamilton; Bruce W Hollis Journal: J Steroid Biochem Mol Biol Date: 2013-01-10 Impact factor: 4.292